WAPPINGERS FALLS, N.Y., Jan. 26 /PRNewswire/ -- Laerdal Medical Corporation today announced a new relationship with Medical Simulation Corporation (MSC), the recognized leader in providing full-service simulation training, education and consulting services to the healthcare industry, in which the companies will jointly offer simulation courseware designed to run on Laerdal's SimMan product family.
The courses, Moderate Sedation and Sepsis, help healthcare professionals across disciplines learn and develop the necessary skills to sedate patients or identify and treat patients at risk for developing sepsis in a safe, controlled environment that does not involve real patients.
Both courses offer Web-based curricula, simulation workshops, and simulation scenarios using Laerdal SimMan patient simulators. The courses were developed in response to the growing need in hospitals to address patient safety goals and quality initiatives driven by The Joint Commission, the Agency for Healthcare Research and Quality and the Institute for Healthcare Improvement, among others.
The Moderate Sedation course is based on guidelines developed by The Joint Commission, American Society of Anesthesiologists and American Association of Nurse Anesthetists, and is suitable for any healthcare provider involved in the administration, assessment and monitoring of patients receiving moderate sedation medications. The Joint Commission requires that hospitals seeking to obtain or maintain accreditation have clear policies for administering moderate and deep sedation and that staff members have appropriate credentials.
The Sepsis program focuses on the early identification, treatment and long-term management of patients with sepsis, and is based on guidelines, tools and research from the Surviving Sepsis Campaign and the Institute for Healthcare Improvement. According to the Surviving Sepsis Web site, sepsis strikes an estimated 750,000 people in the U.S. alone, and is the leading cause of death for critically ill patients in this country. Mortality rates are unacceptably high, and the average cost of treating a patient with sepsis is estimated at $50,000.
"Our new relationship with Medical Simulation Corporation enables Laerdal to deliver comprehensive training solutions to healthcare customers looking to increase staff competence and confidence in delivering moderate sedation and treating patients at risk for developing sepsis," said Joseph Pahlow, vice president of sales, Laerdal. "Hospitals nationwide are increasing their focus on enhancing patient safety and reducing risk, and these courses, with the SimMan simulator the scenarios run on, will help them achieve those goals."
About Medical Simulation Corporation
Medical Simulation Corporation (MSC) is the recognized healthcare industry leader in providing full-service simulation training and education services to healthcare personnel, medical societies and medical product manufacturers. MSC's patient safety solutions are designed to strengthen the competence and confidence of nurses, physicians and technologists. Through its network of training platforms, MSC can provide customized training services to any location worldwide. For more information, please visit www.medsimulation.com or call 888-889-5882.
About Laerdal Medical Corporation
Laerdal Medical, one of the world's leading providers of Healthcare Solutions, is dedicated to helping save lives with products and services for Simulation, Airway Management, Immobilization, Basic Life Support, Advanced Life Support, Patient Care, Self-Directed Learning, and Medical Education. Laerdal is pleased to serve all healthcare providers and educators, from the lay rescuer to the medical professional. For more information, visit http://www.laerdal.com or call 877-523-7325.
Contact: Wendy Troncone, +1-845-297-7770, email@example.com
SOURCE Laerdal Medical Corporation
|SOURCE Laerdal Medical Corporation|
Copyright©2010 PR Newswire.
All rights reserved